Sanofi

YTD

ALL

Why Robinhood?

You can watch Sanofi and buy or sell other stocks, ETFs, and their options commission-free!

About SNY

Sanofi engages in the research, production, and distribution of pharmaceutical products. It operates through the Biopharma segment, which comprises commercial operations and research, development and production activities relating to the specialty care, general medicines and vaccines franchises plus support and corporate functions, for all geographical territories.

CEO

Paul Hudson

CEOPaul Hudson

Employees

84,587

Employees84,587

Headquarters

Paris, Ile-de-France

HeadquartersParis, Ile-de-France

Founded

1994

Founded1994

Employees

84,587

Employees84,587

SNY Key Statistics

Market cap

122.83B

Market cap122.83B

Price-Earnings ratio

12.58

Price-Earnings ratio12.58

Dividend yield

3.16%

Dividend yield3.16%

Average volume

2.79M

Average volume2.79M

High today

$50.54

High today$50.54

Low today

$49.94

Low today$49.94

Open price

$50.45

Open price$50.45

Volume

1.55M

Volume1.55M

52 Week high

$60.12

52 Week high$60.12

52 Week low

$44.62

52 Week low$44.62

SNY News

TipRanks 6h

Sanofi Issues $3 Billion in Notes to Bolster Financial Strategy

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to...

Simply Wall St 3d

The Bull Case For Novavax Could Change Following EU Vaccine Transfer Deal With Sanofi

On October 7, Novavax completed the transfer of its COVID-19 vaccine, Nuvaxovid, to Sanofi, granting Sanofi full commercial and regulatory responsibility for th...

TipRanks 5d

Sanofi’s New Study on Balinatunfib: A Potential Game-Changer for IBD Treatment

Sanofi ((SNYNF)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock p...

More SNY News

Nasdaq 7d

Medidata And Sanofi Expand Collaboration To Advance Clinical Research Innovation

(RTTNews) - Medidata, a Dassault Systèmes brand and a leading provider of clinical trial solutions for the life sciences industry, announced an extension of its...